Breakthrough drugs replace many more invasive services
As some drugs on the market become more successful, this could create a reduced demand for certain clinical interventions, such as amputations. Cardiologists may see fewer referrals as chronic diseases become better managed. Pharmaceutical interventions become more sophisticated and effective.
Research in macro trends in pharmaceutical innovations suggest the industry continues to be committed to innovations. The future also looks bright with the possibility of a large relative increase in new drugs coming to market. Breakthrough drugs will affect the health and social care sector in terms of demand for services and service delivery. One area that might be particularly impacted is invasive services. As pharmaceutical interventions become more sophisticated and effective, conditions that previously required complicated invasive procedures can be managed with easily administered drugs. This may lead to an increase in life expectancy or the average number of years spent in good health. This may have an impact on roles and the workforce’s skills mix. Some roles may be lost as demand for services fall, and the workforce’s overall skill mix must match the changing services on offer. As innovations and new products progress through the development pipeline, service providers, commissioners, education providers etc. all need to be aware of possible implications the product may have if it comes to market, and plan early to best manage the risks and opportunities.
Key facts
Analysis
Forward looking advice
Some of the information in this section is provided by stakeholders and expert groups, and does not necessarily represent the views of the CfWI.
""
"No Demand"